View
225
Download
0
Category
Tags:
Preview:
Citation preview
Global medtech R&D expenditure is forecast to grow by
3.3% (CAGR) to $25.3B
Roche will lead the In Vitro Diagnostics market with sales of $9.9B,
commanding an 18% market share
Medtronic to remain No.1 Cardiology company with global sales
of $10.4B and a market share of 21%
Synthes acquisition will vault Johnson & Johnson to the No. 1 position
in the Orthopedics market with an expected market share of 30%
Worldwide medtech sales forecast
to total
$440B
MedTech
Source: EvaluateMedTech World Preview 2018
in 2018
3 21
Top 20 Medtech Companies
Top 15 Categories & Total Market
Medtech R&D Spend 2011/18 (millions)
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Ear, Nose & Throat (ENT)6.0%
Neurology6.1% In Vitro Diagnostics (IVD)4.4%
Dental4.4%
General & Plastic Surgery5.7%Diabetic Care4.3%
Nephrology2.8%
Healthcare IT3.3%
Cardiology4.3%
Ophthalmics5.7%
Endoscopy5.5%
Diagnostic Imaging3.5%
Drug Delivery 3.6%
Wound Management4.6% Orthopedics3.1%
mddionline.com
Medtech R&D ($m) Company 2011 2018 CAGR 11-18
1 Johnson & Johnson 1,751 2,072 +2% 2 Siemens 1,674 1,987 +2% 3 Medtronic 1,490 1,814 +3% 4 General Electric 949 1,166 +3% 5 Philips 986 1,101 +2% 6 Roche 1,018 1,047 +0% 7 Boston Scientific 895 997 +2% 8 Abbott Laboratories 851 996 +2% 9 St. Jude Medical 705 873 +3% 10 Covidien 554 798 +5% 11 Danaher 419 615 +6% 12 Stryker 462 589 +4% 13 Becton Dickinson 476 544 +2% 14 Terumo 308 458 +6% 15 Edwards Lifesciences 246 428 +8% 16 Essilor International 211 343 +7% 17 Olympus 320 338 +1% 18 B. Braun Melsungen 250 327 +4% 19 Intuitive Surgical 122 317 +15% 20 Zimmer 239 292 +3%
Recommended